SlideShare uma empresa Scribd logo
1 de 25
DONE BY: SHAHINBANU GHORI
DEFINITION:
Duplication prescribing is the practice of prescribing multiple
medications for the same indication without a clear distinction of
when one agent should be administered over another.
example for pain, nausea and vomiting, and constipation.
 Misuse of medicine is using of medicine in way other then the
intended use is medicine.
EPIDEMIOLOGY
.
In the USA 800 patients a year and
accounts for nearly 1 in 100 hospital admissions
death occur by duplication of prescribing.
In the UK, the incidence and consequences of
duplication prescribing similar to USA.
In the India 5000 patient death occurs
by duplication prescribing in year.
Survey:
Millions of people world wide addicted by
misuse of drugs.
3,782,000, 60%
1,612,000, 26%
868,000, 14%
Opioid Analgesics
Sedative Hypnotics
Stimulants
Risk factors:
Adverse drug reactions,
Drug drug interaction,
High dose toxicity
Health problems,
Addiction, Accidents,
Poor academic
performance , Legal
trouble
Duplication in prescribing Misuse of medicine
It is harmful for patient, it can cause death.
Hand written prescription.
and
Mostly in PRN medication
for Pain, Nausea, Vomiting,
Constipation.
Sedative hypnotics,
Stimulants,
Pain relief
Opioid analgesics
(Self medication)
Multiple visit to different
doctor or pharmacist.
By doctor
By patient
Let's look at some examples of
duplication in prescribing
88 y/o Female:
Bisacodyl 5mg po daily PRN constipation
Docusate-senna 2 tabs po qHS PRN constipation
Magnesium hydroxide 30ml po Daily PRN constipation
27 y/o Male:
Fentanyl 25 mcg IV q4hr PRN pain
Oxycodone 5mg po PRN moderate pain
Misuse of medication sources:
Sources misuse drugs used for illicit purposes include:
 Pill mills or illegal pain clinics;
Prescription fraud;
 Pharmacy theft;
 Illegal online pharmacies;
 Doctor shopping - the practice of visiting several different
physicians to obtain multiple prescriptions.
The biggest source misused prescription drugs got them from a
friend or relative, either for free, by purchasing them, or stealing.
Risk - Benefits ratio:
Side effects
Toxicity
Unintended consequences
Relief of symptoms
Improved function
Restored quality of life
Benefits Risks
Effect on Risk – Benefits:
Relief of pain
Improved function
Restored quality of life
IT IS NESSASARY TO FOLLOW SOME STRATERGIES TO REDUCE THIS
RISK OF DUPLICATION OF PRESCRBING AND MISUSE OF MEDICINE
Reduction in duplication of
prescribing:
1
CPOE
Computerized provider order entry systems are designed to
replace a hospital's paper-based ordering system. They allow users
to electronically write the full range of orders, maintain an online
medication administration record to minimize the duplication
error, dose, frequency or any type of medication error.
2
CDS
Clinical decision support, discuss with clinical team and then
manage treatment plan.
3
EHR
Electronic Health Record is an electronic version of a patients
medical history, that is maintained by the provider over time, and
may include all of the key administrative clinical data relevant to
that persons care under a particular provider. It is helpful to check
patient past medical history to reduce therapeutic duplication.
OMS
Order-management system is helpful to reduce risk of
medication problem after using these electronic system.
4
• care-plan
development and
communication
physicians,
pharmacists
and nurses
• order
planning
physicians,
pharmacists
and nurses
• order entry
physicians
• order review,
modification,
and fulfillment
physicians,
pharmacists
and nurses
• order review
and
administration
physicians,
pharmacists
and nurses
To be safe and effective, this order-management system must support
the patient's by health care team as it cooperates in performing the
processes:
Before starting of order management system ask patient about home
medication, self medication, diet plan etc.
5
Patient education:
Avoid multidoctors visit
Avoid visiting to different pharmacy
Avoid self medication
Inform your doctor about last prescription, home
medication or any other herb treatment.
If any problem to recognize medication ask pharmacist
before taking.
Reduction strategies to reduce
misuse of medicine:
Developing an effective strategy will require balancing the
needs and concerns of patients, public health, law
enforcement, and the medical community.
Make better use of prescription
drug monitoring programs
PDMPs are centralized databases where authorized users
can access prescribing and dispensing data submitted by
prescribers and pharmacies.
States can ensure that prescribers and pharmacists have
access to accurate, real-time prescription histories to help
them make clinical decisions about whether to prescribe or
dispense prescription drugs.
1
Enhance enforcement by coordinating operations,
providing specialized training,
and strengthening existing laws
 States can improve their law enforcement and regulatory
oversight activities by ensuring a coordinated approach to
investigating and prosecuting cases of misuse of medicine.
2
Ensure proper disposal of
prescription drugs
 The majority of people who misuse prescription drugs get them from friends and
family, many of those drugs are leftover medicines.
 One of the challenges to ensuring proper disposal is a lack of patient education
on proper disposal procedures.
 In general, people do not know how to dispose of medications safely and
responsibly.
 The Drug Enforcement Administration (DEA) is expected to release regulations
on prescription drug disposal but in the meantime states can act to address the
problem of leftover prescription drugs.
 States can help ensure the proper disposal of expired, unwanted, or unused
medication by educating the public, health care providers, law enforcement,
consumers, and policymakers about safe and effective drug disposal methods.
States can consider collaborating with local coalitions, pharmacies, health
professional boards, and the DEA in take-back activities, such as designating times
and places where the public can safely dispose of unused prescription medication.
3
State’s role as regulator
and purchaser of services
 Strategies that states can adopt are increasing educational
opportunities and requirements for health care providers,
adopting guidelines on appropriate prescribing practices, and
restricting when and how patients access drugs misuse.
4
To promote public education
about drug misuse
Much of the public remains unaware of the dangers of drugs misuse.
A common perception persists that prescription drugs are safer than illegal drugs, and
less likely to lead to misuse, because they are prescribed by a health care provider.
 Along with public and private sector partners, states can launch public awareness
campaigns spearheaded by governors to educate the public, providers, public officials,
and state policymakers about the risks associated with drugs misuse.
Many tools and resources already exist that states can use as a foundation for
developing statewide campaigns.
 For example, governors can help promote “Medicine Misuse Project,” a national
education effort and call to action to inform people about the dangers of drug misuse,
safeguard and properly dispose of unused medicine, and eliminate improper prescribing
and dispensing practices.
5
References:
https://www.nga.org/cms/home/nga
 https://www.drugabuse.gov
https://www.ncbi.nlm.nih.gov
www.managedcaremag.com
final duplication and misuse ppt

Mais conteúdo relacionado

Mais procurados

An overveiw on regulation of otc drug product in different country
An overveiw on regulation of otc drug product in different countryAn overveiw on regulation of otc drug product in different country
An overveiw on regulation of otc drug product in different country
Nitin Patel
 
Manufacture of drugs (other than homeopathy)
Manufacture of drugs (other than homeopathy)Manufacture of drugs (other than homeopathy)
Manufacture of drugs (other than homeopathy)
Robin Gulati
 

Mais procurados (20)

Patient data analysis
Patient data analysisPatient data analysis
Patient data analysis
 
Budget preparation and implementation
Budget preparation and implementationBudget preparation and implementation
Budget preparation and implementation
 
An overveiw on regulation of otc drug product in different country
An overveiw on regulation of otc drug product in different countryAn overveiw on regulation of otc drug product in different country
An overveiw on regulation of otc drug product in different country
 
14ab1t0012 dispensing of narcotics and controlled substances
14ab1t0012   dispensing of narcotics and controlled substances14ab1t0012   dispensing of narcotics and controlled substances
14ab1t0012 dispensing of narcotics and controlled substances
 
Drug and therapeutic committee
Drug and therapeutic committee Drug and therapeutic committee
Drug and therapeutic committee
 
Drug Utilization review
Drug Utilization review Drug Utilization review
Drug Utilization review
 
Concept of risk in pharmacoepidemiology Presentation
Concept of risk in pharmacoepidemiology PresentationConcept of risk in pharmacoepidemiology Presentation
Concept of risk in pharmacoepidemiology Presentation
 
Medication adherence
Medication adherenceMedication adherence
Medication adherence
 
Drug information center
Drug  information centerDrug  information center
Drug information center
 
Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy Pharmaceutical care concepts - clinical pharmacy
Pharmaceutical care concepts - clinical pharmacy
 
Medical adherence
Medical adherenceMedical adherence
Medical adherence
 
Detection and monitoring of ADRs
Detection and monitoring of ADRsDetection and monitoring of ADRs
Detection and monitoring of ADRs
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Manufacture of drugs (other than homeopathy)
Manufacture of drugs (other than homeopathy)Manufacture of drugs (other than homeopathy)
Manufacture of drugs (other than homeopathy)
 
Drug information and poison information
Drug information and poison informationDrug information and poison information
Drug information and poison information
 
Pharmacovigilance and role of pharmacist
Pharmacovigilance and role of pharmacistPharmacovigilance and role of pharmacist
Pharmacovigilance and role of pharmacist
 
Patient Information Leafelet
Patient Information LeafeletPatient Information Leafelet
Patient Information Leafelet
 
PHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEEPHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEE
 
Rational drug prescribing to essential drugs
Rational drug prescribing to essential drugsRational drug prescribing to essential drugs
Rational drug prescribing to essential drugs
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 

Semelhante a final duplication and misuse ppt

L1 pharmacotherapy introduction ……...pdf
L1 pharmacotherapy introduction ……...pdfL1 pharmacotherapy introduction ……...pdf
L1 pharmacotherapy introduction ……...pdf
swr88kv5p2
 
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPMMEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
Lipanjali Badhei
 

Semelhante a final duplication and misuse ppt (20)

Rational drug use
Rational drug useRational drug use
Rational drug use
 
Medication Safety- Administration and monitoring.pptx
Medication Safety- Administration and monitoring.pptxMedication Safety- Administration and monitoring.pptx
Medication Safety- Administration and monitoring.pptx
 
Rational drug use
Rational drug useRational drug use
Rational drug use
 
L1 pharmacotherapy introduction ……...pdf
L1 pharmacotherapy introduction ……...pdfL1 pharmacotherapy introduction ……...pdf
L1 pharmacotherapy introduction ……...pdf
 
Essential drug concept & Rational drug use.pptx
Essential drug concept & Rational drug use.pptxEssential drug concept & Rational drug use.pptx
Essential drug concept & Rational drug use.pptx
 
Abuse Of Prescription Drugs
Abuse Of Prescription DrugsAbuse Of Prescription Drugs
Abuse Of Prescription Drugs
 
research 3
research 3research 3
research 3
 
Self medication
Self medicationSelf medication
Self medication
 
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPMMEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
 
Global Medical Cures™ | Responding to America's Prescription Drug Abuse Crisis
Global Medical Cures™ | Responding to America's Prescription Drug Abuse CrisisGlobal Medical Cures™ | Responding to America's Prescription Drug Abuse Crisis
Global Medical Cures™ | Responding to America's Prescription Drug Abuse Crisis
 
RUD and COMPLIANCE
RUD and COMPLIANCERUD and COMPLIANCE
RUD and COMPLIANCE
 
How pharmaceutical companies in India can provide Information therapy
How pharmaceutical companies in India can provide Information therapy  How pharmaceutical companies in India can provide Information therapy
How pharmaceutical companies in India can provide Information therapy
 
Promoting Rational drugs in NRHM
Promoting Rational drugs in NRHMPromoting Rational drugs in NRHM
Promoting Rational drugs in NRHM
 
medication adherence.pdf
medication adherence.pdfmedication adherence.pdf
medication adherence.pdf
 
CLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptxCLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptx
 
HOME MEDICATION REVIEW FOR PHARM D STUDENTS.ppt
HOME MEDICATION REVIEW FOR PHARM D STUDENTS.pptHOME MEDICATION REVIEW FOR PHARM D STUDENTS.ppt
HOME MEDICATION REVIEW FOR PHARM D STUDENTS.ppt
 
Introduction to rational use of drugs and role of pharmacist in rational use...
Introduction to  rational use of drugs and role of pharmacist in rational use...Introduction to  rational use of drugs and role of pharmacist in rational use...
Introduction to rational use of drugs and role of pharmacist in rational use...
 
Pharmacist care services.pptx
Pharmacist care services.pptxPharmacist care services.pptx
Pharmacist care services.pptx
 
Drug use mis use and abuse
Drug use mis use and abuse Drug use mis use and abuse
Drug use mis use and abuse
 
Final dissertation
Final dissertationFinal dissertation
Final dissertation
 

final duplication and misuse ppt

  • 2. DEFINITION: Duplication prescribing is the practice of prescribing multiple medications for the same indication without a clear distinction of when one agent should be administered over another. example for pain, nausea and vomiting, and constipation.  Misuse of medicine is using of medicine in way other then the intended use is medicine.
  • 3. EPIDEMIOLOGY . In the USA 800 patients a year and accounts for nearly 1 in 100 hospital admissions death occur by duplication of prescribing. In the UK, the incidence and consequences of duplication prescribing similar to USA. In the India 5000 patient death occurs by duplication prescribing in year. Survey:
  • 4. Millions of people world wide addicted by misuse of drugs. 3,782,000, 60% 1,612,000, 26% 868,000, 14% Opioid Analgesics Sedative Hypnotics Stimulants
  • 5. Risk factors: Adverse drug reactions, Drug drug interaction, High dose toxicity Health problems, Addiction, Accidents, Poor academic performance , Legal trouble Duplication in prescribing Misuse of medicine It is harmful for patient, it can cause death.
  • 6. Hand written prescription. and Mostly in PRN medication for Pain, Nausea, Vomiting, Constipation. Sedative hypnotics, Stimulants, Pain relief Opioid analgesics (Self medication) Multiple visit to different doctor or pharmacist. By doctor By patient
  • 7. Let's look at some examples of duplication in prescribing 88 y/o Female: Bisacodyl 5mg po daily PRN constipation Docusate-senna 2 tabs po qHS PRN constipation Magnesium hydroxide 30ml po Daily PRN constipation 27 y/o Male: Fentanyl 25 mcg IV q4hr PRN pain Oxycodone 5mg po PRN moderate pain
  • 8. Misuse of medication sources: Sources misuse drugs used for illicit purposes include:  Pill mills or illegal pain clinics; Prescription fraud;  Pharmacy theft;  Illegal online pharmacies;  Doctor shopping - the practice of visiting several different physicians to obtain multiple prescriptions. The biggest source misused prescription drugs got them from a friend or relative, either for free, by purchasing them, or stealing.
  • 9. Risk - Benefits ratio: Side effects Toxicity Unintended consequences Relief of symptoms Improved function Restored quality of life Benefits Risks
  • 10. Effect on Risk – Benefits: Relief of pain Improved function Restored quality of life
  • 11. IT IS NESSASARY TO FOLLOW SOME STRATERGIES TO REDUCE THIS RISK OF DUPLICATION OF PRESCRBING AND MISUSE OF MEDICINE
  • 12. Reduction in duplication of prescribing: 1 CPOE Computerized provider order entry systems are designed to replace a hospital's paper-based ordering system. They allow users to electronically write the full range of orders, maintain an online medication administration record to minimize the duplication error, dose, frequency or any type of medication error.
  • 13. 2 CDS Clinical decision support, discuss with clinical team and then manage treatment plan.
  • 14. 3 EHR Electronic Health Record is an electronic version of a patients medical history, that is maintained by the provider over time, and may include all of the key administrative clinical data relevant to that persons care under a particular provider. It is helpful to check patient past medical history to reduce therapeutic duplication.
  • 15. OMS Order-management system is helpful to reduce risk of medication problem after using these electronic system. 4
  • 16. • care-plan development and communication physicians, pharmacists and nurses • order planning physicians, pharmacists and nurses • order entry physicians • order review, modification, and fulfillment physicians, pharmacists and nurses • order review and administration physicians, pharmacists and nurses To be safe and effective, this order-management system must support the patient's by health care team as it cooperates in performing the processes: Before starting of order management system ask patient about home medication, self medication, diet plan etc.
  • 17. 5 Patient education: Avoid multidoctors visit Avoid visiting to different pharmacy Avoid self medication Inform your doctor about last prescription, home medication or any other herb treatment. If any problem to recognize medication ask pharmacist before taking.
  • 18. Reduction strategies to reduce misuse of medicine: Developing an effective strategy will require balancing the needs and concerns of patients, public health, law enforcement, and the medical community.
  • 19. Make better use of prescription drug monitoring programs PDMPs are centralized databases where authorized users can access prescribing and dispensing data submitted by prescribers and pharmacies. States can ensure that prescribers and pharmacists have access to accurate, real-time prescription histories to help them make clinical decisions about whether to prescribe or dispense prescription drugs. 1
  • 20. Enhance enforcement by coordinating operations, providing specialized training, and strengthening existing laws  States can improve their law enforcement and regulatory oversight activities by ensuring a coordinated approach to investigating and prosecuting cases of misuse of medicine. 2
  • 21. Ensure proper disposal of prescription drugs  The majority of people who misuse prescription drugs get them from friends and family, many of those drugs are leftover medicines.  One of the challenges to ensuring proper disposal is a lack of patient education on proper disposal procedures.  In general, people do not know how to dispose of medications safely and responsibly.  The Drug Enforcement Administration (DEA) is expected to release regulations on prescription drug disposal but in the meantime states can act to address the problem of leftover prescription drugs.  States can help ensure the proper disposal of expired, unwanted, or unused medication by educating the public, health care providers, law enforcement, consumers, and policymakers about safe and effective drug disposal methods. States can consider collaborating with local coalitions, pharmacies, health professional boards, and the DEA in take-back activities, such as designating times and places where the public can safely dispose of unused prescription medication. 3
  • 22. State’s role as regulator and purchaser of services  Strategies that states can adopt are increasing educational opportunities and requirements for health care providers, adopting guidelines on appropriate prescribing practices, and restricting when and how patients access drugs misuse. 4
  • 23. To promote public education about drug misuse Much of the public remains unaware of the dangers of drugs misuse. A common perception persists that prescription drugs are safer than illegal drugs, and less likely to lead to misuse, because they are prescribed by a health care provider.  Along with public and private sector partners, states can launch public awareness campaigns spearheaded by governors to educate the public, providers, public officials, and state policymakers about the risks associated with drugs misuse. Many tools and resources already exist that states can use as a foundation for developing statewide campaigns.  For example, governors can help promote “Medicine Misuse Project,” a national education effort and call to action to inform people about the dangers of drug misuse, safeguard and properly dispose of unused medicine, and eliminate improper prescribing and dispensing practices. 5